ZC3HAV1 and thyroid cancer: A number of BRAF fusions are, however, novel (Fig. 1, Supplementary Fig. 5), including ATG7–BRAF in melanoma, as well as ZC3HAV1–BRAF and FAM114A2–BRAF in thyroid cancer.